
Paris, France
May Health is developing a modern treatment - Ovarian Rebalancing - designed to restore ovulation for people with polycystic ovary syndrome (PCOS). It is a clinical-stage medical device company committed to developing treatment options for women living with PCOS.
- Revenue
- $10M
- Customers
- -
- Year founded
- 2017
- Funding
- -
- Team size
- 29
- Growth
- -








